RANCHO CORDOVA, Calif., June 16, 2011 /PRNewswire/ —
ThermoGenesis Corp. (NASDAQ:
KOOL), a leading supplier of innovative products and services
that process and store adult stem cells, said today it will be
participating in the OnemedForumNY 2011 Conference on Thursday,
June 23.
The presentation by J. Melville Engle, Chairman and Chief
Executive Officer, will begin at 9:45 a.m., Eastern Daylight Time
(6:45 a.m., Pacific Daylight Time).
The presentation will be available through the conference
website at http://www.onemedplace.com.
A replay of the webcast will be available for 60 days beginning
July 1 on the Company’s website at
www.thermogenesis.com/investors-webcasts-and-calls.aspx.
About ThermoGenesis Corp.
ThermoGenesis Corp. (www.thermogenesis.com) is a
leader in developing and manufacturing automated blood processing
systems and disposable products that enable the manufacture,
preservation and delivery of cell and tissue therapy products.
These include:
- The BioArchive® System, an automated cryogenic device, used
by cord blood stem cell banks in more than 30 countries for
cryopreserving and archiving cord blood stem cell units for
transplant. - AXP® AutoXpress™ Platform (AXP), a proprietary family
of automated devices that includes the AXP and the MXP™
MarrowXpress™ and companion sterile blood processing
disposables for harvesting stem cells in closed systems. The AXP
device is used for the processing of cord blood. The MXP is used
for the preparation of cell concentrates, including stem cells,
from bone marrow aspirates in the laboratory setting. - The Res-Q™ 60 BMC (Res-Q), a point-of-care syste
‘/>”/>
